Qiagen N.V. Stock price

Equities

QGEN

NL0015001WM6

Biotechnology & Medical Research

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
44.14 USD +0.23% Intraday chart for Qiagen N.V. -1.95% -1.41%
Sales 2024 * 2.01B Sales 2025 * 2.16B Capitalization 9.77B
Net income 2024 * 397M Net income 2025 * 446M EV / Sales 2024 * 5 x
Net Debt 2024 * 303M Net cash position 2025 * 281M EV / Sales 2025 * 4.4 x
P/E ratio 2024 *
24.9 x
P/E ratio 2025 *
21.9 x
Employees 5,361
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.49%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.23%
1 week-0.72%
Current month+3.15%
1 month+2.51%
3 months+0.86%
6 months+4.23%
Current year-1.41%
More quotes
1 week
43.69
Extreme 43.69
45.07
1 month
42.27
Extreme 42.27
45.07
Current year
42.17
Extreme 42.17
47.29
1 year
35.81
Extreme 35.8144
49.18
3 years
35.81
Extreme 35.8144
59.79
5 years
25.81
Extreme 25.8144
60.82
10 years
20.83
Extreme 20.8335
60.82
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 15-01-31
Founder 69 96-04-28
Director of Finance/CFO 56 98-12-31
Members of the board TitleAgeSince
Director/Board Member 75 11-05-31
Founder 69 96-04-28
Chairman 66 13-06-25
More insiders
Date Price Change Volume
24-03-18 44.14 +0.23% 636,339
24-03-15 44.04 +0.05% 1,032,057
24-03-14 44.02 -0.61% 720,883
24-03-13 44.29 -0.78% 823,185
24-03-12 44.64 -0.84% 594,636

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid). In 2022, the group developed more than 500 core consumable products and automated solutions through its over 35 locations worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (34.2%), the United States (42.5%), America (4.1%) and other (19.2%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
44.14 USD
Average target price
51 USD
Spread / Average Target
+15.55%
Consensus
  1. Stock
  2. Equities
  3. Stock Qiagen N.V. - Nyse